Prevalence of gastroduodenal mucosal injury in a symptomatic patients taking antiplatelet agents in Japan

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 12, 2009, Pages 722-725

  Yamamoto, T ^a,b   Isono, A ^a   Ebato, T ^a   Mishina, Y ^a   Shirasaki, Y ^a   Abe, K ^a   Hattori, K ^a   Ishii, T ^a   Kuyama, Y ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Antiplatelets; Low dose aspirin; Mucosal injury

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; DICLOFENAC; LORNOXICAM; LOXOPROFEN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; TICLOPIDINE;

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; JAPANESE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; RHEUMATOID ARTHRITIS; STOMACH MUCOSA INJURY;

EID: 71849090989     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47722     Document Type: Article

References (13)

1. Derry S, Loke YK. Risk of gastrointestinal hemorrhage with long term use of aspirin: meta-analysis. Br Med J. 2000; 321: 1183-1187.
2. Douglas JSJ, Holmes DRJ, Kereisakes DJ, Grines CL, Block E, Ghazzal AM, Morris DC, Liberman H, Parker K, Jurkovitz C, Murrah N, Foster J, Hyde P, Mancini GB, Weintraub WS. Cilostazol for Restenosis Trial (CREST) Investigators. Coronary stent restenosis in patients treated with cilostazol. Circulation. 2005; 112: 2826-2832.
3. Garcia Rodriguez LA, Hernandez-Diaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies. Br J Clin Pharmacol. 2001; 52: 563-571.
4. Ibanez L, Vidal X, Vendrell L, Moretti U, Laporte JR. Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Upper gastrointestinal bleeding associated with antiplatelet drug. Aliment Pharmacol Ther. 2006; 23: 235-242.
5. Kwon SU, Cho YJ, Koo JS, Bae HJ, Lee YS, Hong KS, Lee JH, Kim JS. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005; 36: 782-786.
6. Lanas A, Garcia-Rodoriguez LA, Arroyo MT, Gomollon F, Feu F, Gonzalez-Perez A, Zapata E, Bastida G, Rodrigo L, Santolaria S, Guell M, de Argila CM, Quintero E, Borda F, Pique JM. Asociacion Espanola de Gastroenterologia. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006; 55: 1731-1738.
7. Mansoor GA, Aziz K. Delayed chronic diarrhea and weight loss possibly due to ticlopidine therapy. Ann Pharmacother. 1997; 31: 870-872.
8. Niv Y, Battler A, Abuksis G, Gal E, Sapoznikov B, Vilkin A. Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci. 2005; 50: 78-80.
9. Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J, Mizokami Y, Mine T, Arakawa T, KuwayamaH, Saigenji K, Yakabi K, Chiba T, Shimosegawa T, Sheehan JE, Perez-Gutthann S, Yamaguchi T, Kaufman DW, Sato T, Kubota K, Terano A. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol. 2006; 62: 765-772.
10. Sheikh RA, Romano PS, Prindiville TP, Yasmeen S, Trudeau W. Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal anti-inflammatory drugs and controls. J Clin Gastroenterol. 2002; 34: 529-532.
11. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002; 162: 2197.
12. Yamamoto T, Sanaka M, Nagasawa K, Abe K, Fukami M, Nakayama S, Tsuchiya A, Ishii T, Kuyama Y. Gastroduodenal mucosal injury in patients on antiplatelet therapy. Thromb Res. 2007; 120: 465-469.
13. Yeomans ND, Lanas AI, Talley NJ, Thomson AB, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Lanqstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005; 22: 795-801.